BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND hCG AND Staging
72 results:

  • 1. Nongestational ovarian choriocarcinoma with bilateral teratoma: A rare case report and literature review.
    Ao X; Hu S; Tan S; Xiong W
    Medicine (Baltimore); 2024 May; 103(18):e36996. PubMed ID: 38701311
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors.
    Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
    Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.
    Dieckmann KP; Dumlupinar C; Grobelny F; Utschig J; Klemke M; Ahmed Saad EM; Wülfing C; Pichlmeier U; Isbarn H; Belge G
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7079-7090. PubMed ID: 36869885
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. French AFU cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
    Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
    Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serum tumour markers in germ cell tumours: From diagnosis to cure.
    Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
    Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Institutional results of OncoOVARIAN Dx - a novel algorithm for the preoperative evaluation of adnexal masses.
    Kubelac P; Craciun A; Jalba O; Gheorghe S; Lazar G; Ignat F; Lisencu C; Rancea A; Vlad C; Irimie A; Achimas Cadariu P
    J BUON; 2020; 25(3):1658-1663. PubMed ID: 32862619
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
    Aydos U; Tahtaci G; Özgür Akdemir Ü; Özet A
    Nucl Med Commun; 2020 Nov; 41(11):1199-1209. PubMed ID: 32796455
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
    Castro BGR; Souza CP; Andrade CEMDC; Vieira MA; Andrade DAP; Reis RD
    Rev Bras Ginecol Obstet; 2019 Jul; 41(7):440-448. PubMed ID: 31344718
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.
    Kollmannsberger CK; Nappi L; Nichols C
    J Clin Oncol; 2019 Aug; 37(22):1856-1862. PubMed ID: 31180818
    [No Abstract]    [Full Text] [Related]  

  • 10. The role of
    Hung TJ; McLean L; Mitchell C; Pascoe C; Lawrentschuk N; Murphy DG; Iravani A; Singh D; Hofman MS; Zidan L; Akhurst T; Lewin J; Hicks RJ
    Cancer Imaging; 2019 May; 19(1):28. PubMed ID: 31142361
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT).
    Hassan O; Epstein JI
    Am J Surg Pathol; 2018 Aug; 42(8):1113-1120. PubMed ID: 29794869
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Role of radiotherapy in stage I testicular seminomas: about 25 cases].
    Aissa A; Marnouche E; Elkacemi H; Kebdani T; Benjaafar N
    Pan Afr Med J; 2016; 25():53. PubMed ID: 28250877
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
    Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
    Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [CCAFU Recommendations 2013: Testicular germ cell cancer].
    Durand X; Rigaud J; Avancès C; Camparo P; Fléchon A; Murez T; Sèbe P; Culine S; Iborra F; Mottet N; Coloby P; Soulié M;
    Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A pelvic mass on ultrasonography and high human chorionic gonadotropin level: not always an ectopic pregnancy.
    Rozenholc A; Abdulcadir J; Pelte MF; Petignat P
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22669919
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
    Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
    Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular cancer Group.
    Olofsson SE; Tandstad T; Jerkeman M; Dahl O; Ståhl O; Klepp O; Bremnes RM; Cohn-Cedermark G; Langberg CW; Laurell A; Solberg A; Stierner U; Wahlqvist R; Wijkström H; Anderson H; Cavallin-Ståhl E
    J Clin Oncol; 2011 May; 29(15):2032-9. PubMed ID: 21482994
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The role of tumour markers in diagnosis and management of testicular germ cell tumours].
    Krege S; Albers P; Heidenreich A
    Urologe A; 2011 Mar; 50(3):313-21. PubMed ID: 21327901
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.